PURR enters June having just delivered one of the stronger weeks in its short history as a listed company — up nearly 30% over the past five trading days to $10.97, and more than 75% higher than a month ago. The divergence between a rallying stock and a Street that hasn't fully caught up is the defining tension heading into the week ahead.
The most striking feature of the past month is how dramatically the short-selling setup has unwound. Shares sold short peaked above 11.3 million in mid-May at the height of bearish conviction, before sliding to roughly 7.4 million by June 2 — a decline of around 35% in just three weeks. That unwind tracks almost perfectly with the stock's rally. The borrow cost, which topped 3.8% in early May and was still running near 3% in mid-month, has since collapsed to just 1.17%, its lowest level over the past six weeks. Availability is extremely loose at over 1,000% relative to short interest — a signal that there is no shortage of shares to borrow and no meaningful squeeze pressure in the lending pool. The short score, meanwhile, has pulled back from a recent high near 50 in late May to 40.5, consistent with the fading bearish positioning.
Options traders are not especially alarmed. The put/call ratio is running at 0.18, slightly below its 20-day average of 0.18 and nowhere near the 52-week high of 0.67. The z-score is modestly negative, suggesting call-side demand is holding up relative to recent norms. That calm contrasts with the elevated caution embedded in the stock earlier in May — the positioning now reflects momentum-chasing rather than hedging.
The Street has started to chase the move, though with a lag. Chardan Capital raised its target to $9.75 from $8.45 in late May. Cantor Fitzgerald lifted its Overweight target to $8.00 from $6.00 earlier in the month. Maxim Group initiated in late April with a Buy and a $10.00 target. The consensus price target averages around $9.58 — which, against a current price of $10.97, means the stock has now run through analyst estimates and is trading at a premium to where the Street thought it would go. The bulls see compounding growth from rising average daily trading volume on the Hyperliquid platform, which moved from $330 million daily in late 2023 to $6.4 billion recently, alongside a HIP-3 protocol upgrade expected in Q4. Bears point to a steep fall in the value of the HYPE token — the company's primary asset — from a $58.58 peak to below $25, and to intensifying competition from Aster, Lighter, and edgeX, which have been using aggressive incentive programs to chip away at Hyperliquid's market share.
Institutional ownership tells an interesting story. D1 Capital Partners holds nearly 6% of the company at 8 million shares, with no change reported in Q1. Paradigm Operations, a crypto-native manager, sits at 4.2%. State Street and BlackRock both added full new positions in April — 3.1 million and 2.1 million shares respectively — a meaningful signal that passive and index-adjacent flows are beginning to recognise the name. On the other side, Pantera Capital trimmed by 1.4 million shares in Q1, and Galaxy Group cut aggressively, reducing its position by 3.4 million shares. The divergence between crypto-native sellers and traditional asset manager buyers captures the stock's identity tension perfectly.
The recent earnings history adds a note of caution. The last two prints both saw initial negative reactions of -0.3% and -3.0% on the day, before recovering to positive 5-day returns of 6.7% and 3.2% respectively. The February event was harder, with a -8.0% day-one move and a -11.9% five-day slide. No next earnings date is confirmed, but the pattern of buying the dip after initial weakness is worth noting given the stock is now running well above analyst targets. The key variable to watch next is whether the HYPE token price stabilises — and whether the HIP-3 launch timeline firms up enough to give the bull case a near-term catalyst to anchor.
See the live data behind this article on ORTEX.
Open PURR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
